Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial

Hunter R. Underhill, Chun Yuan, Xue Qiao Zhao, Larry W. Kraiss, Dennis L. Parker, Tobias Saam, Baocheng Chu, Norihide Takaya, Fei Liu, Nayak L. Polissar, Blazej Neradilek, Joel S. Raichlen, Valerie A. Cain, John C. Waterton, Wendy Hamar, Thomas S. Hatsukami

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Magnetic resonance imaging (MRI) can noninvasively assess changes in atherosclerotic plaque morphology and composition. The ORION trial assessed the effects of rosuvastatin on carotid plaque volume and composition. Methods: The randomized, double-blind ORION trial used 1.5-T MRI to image carotid atherosclerotic plaques at baseline and after 24 months of treatment. Forty-three patients with fasting low-density lipoprotein cholesterol ≥100 and
    Original languageEnglish
    Pages (from-to)584-e8
    JournalAmerican Heart Journal
    Volume155
    Issue number3
    DOIs
    Publication statusPublished - Mar 2008

    Fingerprint

    Dive into the research topics of 'Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial'. Together they form a unique fingerprint.

    Cite this